Single-cell sequencing in non-obstructive azoospermia: insights from primary and re-analysis studies. [PDF]
Jiang Z +6 more
europepmc +1 more source
Impact of AZFc deletion subtypes on sperm retrieval rates via micro-TESE and ICSI outcomes in non-obstructive azoospermia patients. [PDF]
Xia Y +5 more
europepmc +1 more source
The power of the map: testicular mapping to guide surgical sperm retrieval in patients with non-obstructive azoospermia. [PDF]
Amighi A +7 more
europepmc +1 more source
Global Andrology Forum (GAF) Clinical Guidelines on the Management of Non-obstructive Azoospermia: Bridging the Gap between Controversy and Consensus. [PDF]
Hamoda T +52 more
europepmc +1 more source
Varicocele treatment in non-obstructive azoospermia: a systematic review [PDF]
Objective: To review the available literature and identify factors associated with successful outcomes after varicocele repair (VR) in the setting of non-obstructive azoospermia (NOA). Methods: The PubMed and EMBASE databases were searched for relevant articles.
Edmund Ko, Stephanie Jensen
exaly +3 more sources
Related searches:
Kallman syndrome and central non-obstructive azoospermia
Best Practice and Research in Clinical Endocrinology and Metabolism, 2020The understanding of male factors of infertility has grown exponentially in the past ten years. While clear guidelines for obstructive azoospermia have been developed, management of non-obstructive azoospermia has lagged. Specifically, management of Kallmann Syndrome and central non-obstructive azoospermia has been limited by a lack of understanding of
Sameer Thakker, Bobby Najari
exaly +3 more sources
Medical management of non-obstructive azoospermia: A systematic review [PDF]
While most men with non-obstructive azoospermia (NOA) are not amenable to medical treatment, some men can be treated effectively with hormonal therapy, prior to considering surgery. In some cases, hormonal therapy alone can treat NOA, without the need for surgery.
Armand Zini, Mohammad Alkandari
exaly +3 more sources
Ooplasmic injections of secondary spermatocytes for non-obstructive azoospermia
THE LANCET • Vol 351 • April 18, 1998 1177 difference in frequency of IOL, instrumental vaginal delivery, or Caesarean section between the groups. There was a trend towards a greater number of elective Caesareans among doctors (6/10 of the doctors elective Caesareans were by maternal request compared to 2/7 of the matched controls). Although the number
Nikolaos Sofikitis +2 more
exaly +5 more sources
Microsurgical TESE and the distribution of spermatogenesis in non-obstructive azoospermia [PDF]
We wished to map the distribution of spermatogenesis in different regions of the testis in 58 men with non-obstructive azoospermia, and to develop a rational microsurgical strategy for the testicular sperm extraction (TESE) procedure. One goal was to maximize the chances for retrieving spermatozoa from such men, to minimize tissue loss and pain, and to
Sherman Silber, Silber Sherman J
exaly +3 more sources
Biological therapy for non-obstructive azoospermia
Expert Opinion on Biological Therapy, 2017Most male patients with non-obstructive azoospermia (NOA) have no therapeutic options outside of assisted reproductive techniques to conceive a biological child. If mature sperm cannot be obtained from the testes, these patients must rely on options of donor sperm or adoption.
Sarah C, Vij +2 more
openaire +2 more sources

